Background: Current massive transfusion guidelines are derived from washout equations that may not apply to bleeding trauma patients. Our aim was to analyze these guidelines using a computer simulation.
Methods: A combined hemodilution and hemodynamic model of an exsanguinating patient was developed to calculate the changes in prothrombin time (PT), fibrinogen, and platelets with bleeding. The model was calibrated to data from 44 patients. Time intervals to subhemostatic values of each coagulation test were calculated for a range of replacement options.
Results: Prolongation of PT is the sentinel event of dilutional coagulopathy and occurs early in the operation. The key to preventing coagulopathy is plasma infusion before PT becomes subhemostatic. The optimal replacement ratios were 2:3 for plasma and 8:10 for platelets. Concurrent transfusion of plasma with blood is another effective strategy for minimizing coagulopathy.
Conclusion: Existing protocols underestimate the dilution of clotting factors in severely bleeding patients. The model presents an innovative approach to optimizing component replacement in exsanguinating hemorrhage.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.TA.0000053245.08642.1F | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Altered thrombin generation with prothrombin complex concentrate is not detected by viscoelastic testing: an in vitro study.
Br J Anaesth
January 2025
Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, Vienna, Austria; Department of Anesthesiology and Intensive Care Medicine AUVA Trauma Center Salzburg, Academic Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria.
Background: Bleeding guidelines currently recommend use of viscoelastic testing (VET) to direct haemostatic resuscitation in severe haemorrhage. However, VET-derived parameters of clot initiation, such as clotting time (CT) and activated clotting time (ACT), might not adequately reflect a clinically relevant interaction of procoagulant and anticoagulant activity, as revealed by thrombin generation assays. The aim of this study was to evaluate the ability of CT and ACT to indicate thrombin generation activity.
View Article and Find Full Text PDFDetection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro.
Sci Rep
November 2024
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Wien, Vienna, 1090, Austria.
Article Synopsis
- The study investigates point-of-care diagnostic tests for monitoring the anticoagulants enoxaparin and argatroban in critically ill patients who face risks of thrombosis and bleeding.
- Blood samples from twelve healthy volunteers were used to evaluate the performance of the ClotPro viscoelastic coagulometer alongside traditional coagulation tests.
- Results indicated that the RVV test for enoxaparin is not reliable, while the ECA test shows strong correlation and may be a better option for accurately detecting argatroban levels.
Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Cureus
October 2024
Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, USA.
Article Synopsis
- - Hemorrhage is the main cause of preventable death in trauma situations, leading to military and civilian advancements in medical practices, particularly through the use of tourniquets to manage extremity bleeding and save lives.
- - While tourniquets have significantly decreased deaths from bleeding in military settings, noncompressible hemorrhage still poses a major risk, especially before patients receive definitive medical care.
- - The study explores using a small, disposable pressure monitor during resuscitative endovascular balloon occlusion of the aorta (REBOA) to enhance blood pressure monitoring, facilitate better resuscitation practices, and reduce the need for blood products in extreme environments.
The (reverse) paradox of lupus anticoagulant: A case report.
Lupus
October 2024
Department of Rheumatology, Max Super Speciality Hospital, New Delhi, India.
Article Synopsis
- Systemic Lupus Erythematosus (SLE) often coexists with antiphospholipid syndrome, leading to blood clotting issues or complications in pregnancy, as illustrated by a case of a 7-year-old girl experiencing fever, bleeding, and thrombophlebitis.
- The child presented with symptoms like gum bleeding, small skin lesions, and abnormal blood coagulation tests, prompting further investigation for an autoimmune disorder.
- Ultimately, she was diagnosed with Systemic Lupus Erythematosus and Lupus Anticoagulant Hypoprothrombinemia Syndrome after confirming the presence of specific antibodies and coagulation abnormalities.
TXA combined with whole blood transfusion in trauma patients does not increase the risk of VTE but shock index does.
Am J Surg
December 2024
University of Texas Health Science Center at San Antonio, Department of Trauma and Emergency Surgery, San Antonio, TX, USA.
Introduction: Previous studies have demonstrated the benefits of tranexamic acid (TXA) administration in combination with packed red blood cell (PRBC) transfusion in trauma patients without increasing the risk of venous thromboembolism (VTE). However, the effect of TXA in combination with whole blood (WB) has not been studied. Injury, abbreviated injury severity scores (ISS and AIS) and the need for blood transfusions are historically associated with VTE.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!